• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Ter . Patient safety recommendations and management in patients with COVID-19 pneumonia suspicion: a retrospective study

tetano

Editor, Senior Moderator
Clin Ter


. 2021 May 5;172(3):225-230.
doi: 10.7417/CT.2021.2319.
Patient safety recommendations and management in patients with COVID-19 pneumonia suspicion: a retrospective study


A Piccioni[SUP] 1 [/SUP], L Franza[SUP] 2 [/SUP], F Rosa[SUP] 2 [/SUP], S Cicchinelli[SUP] 3 [/SUP], A Saviano[SUP] 2 [/SUP], F Valletta[SUP] 2 [/SUP], T de Cunzo[SUP] 2 [/SUP], C Zanza[SUP] 2 [/SUP], M Covino[SUP] 3 [/SUP], V Ojetti[SUP] 3 2 [/SUP], F Franceschi[SUP] 2 [/SUP], F Franceschi[SUP] 3 [/SUP], M Candelli[SUP] 4 [/SUP]



Affiliations

Abstract

Objective: Since December 2019, new pneumonia of unknown aetiology broke out in Wuhan, Hubei province, China. Subsequently, a virus, later named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the causative agent of the disease. Currently, the epidemic has spread all over the world. The most common manifestations of COVID-19 are fever, fatigue and dry cough. At the moment, the nuclide acid test is the gold standard method for the diagnosis of this infection.
Methods: In the present paper, we report our experience with all patients who came to the Emergency Department from March 1 to April 1, 2020, with suggestive symptoms of COVID-19 infection. Patients: they all underwent a first oropharyngeal and nasopharyngeal swab in the emergency department and, if negative, a second one after at least 24 hours.
Results: Our study shows how the results obtained at time zero are usually identical to the ones obtained after 24 hours. We thus suggest, in patients with high suspicion of COVID19 and a negative result at the first swab, to repeat the test after at least 48 hours, during which patients with symptoms of COVID-19 pneumonia disease should be kept in isolation to avoid the risk of contagion.
Conclusions: these measures and in particular the early identifica-tion of cases with consequent isolation will allow the containment of the spread of the virus, representing one of the fundamental measures to guarantee and strengthen the control of the infection to reduce hospital admissions, the overload of national health service and health costs.

Keywords: COVID-19; Emergency Department; Pandemic; RT-PCR; Risk management; SARS-CoV-2.
 
Back
Top Bottom